A phase II study of cisplatin and irinotecan as induction chemotherapy followed by accelerated hyperfractionated thoracic radiotherapy with daily low-dose carboplatin in unresectable stage III non-small cell lung cancer: JCOG 9510.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples